Hozumi H

No ORCID on file · 1 paper in corpus
rct 2025
Reproductive medicine and biology ·doi:10.1002/rmb2.12700

PURPOSE: To evaluate the applicability of overseas-approved dosage of relugolix combination tablets (relugolix 40 mg, estradiol [E2] 1 mg, and norethisterone acetate 0.5 mg) in healthy premenopausal Japanese women. METHODS: A randomized, d…